HOME | CONTACT

See Nektar's R&D pipeline of products in clinical development »
Learn more about our clinical trials »
See Nektar partners and case studies »
News Headlines
January 05 Baxter Initiates Phase I Clinical Trial of Longer-Acting Recombinant FVIII Treatment for Hemophilia A »
Events Calendar
Jan. 11, 2012 J.P. Morgan Healthcare Conference
8:30 AM Pacific Time
Listen to this webcast
View Presentation
Nov. 2, 2011 Q3 2011 Nektar Financial Results Conference Call
2:00 PM Pacific Time
Listen to this webcast
Dial in replay Information:
U.S. (888) 286-8010
International (617) 801-6888
Passcode 41636531
Media Highlights
BioCentury features Phase 1 NKTR-181 data in the Bernstein Report on BioBusiness
Drug Discovery News interviews Nektar's chief medical officer, Dr. Robert Medve, on NKTR-181 Phase 1 Data
Dr. Agustin Garcia presents NKTR-102 data in an oral abstract session at the 2011 ASCO Breast Cancer Symposium
Watch video clip »
 
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide Copyright Nektar © 2012